Sara Lustigman

New York Blood Center — United States

Medicine · Health Sciences

49h-index8.1kcitations202works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parasitic Diseases Research and Treatment(128), Parasites and Host Interactions(80), Parasite Biology and Host Interactions(74), Insect symbiosis and bacterial influences(43), Insects and Parasite Interactions(22)

Publications202 total

Vaccination against Onchocerca volvulus induces IgG-mediated protective immunity dependent on neutrophils and complement
npj Vaccines·2025Open Access
Fexinidazole and Corallopyronin A target Wolbachia-infected sheath cells present in filarial nematodes
PLoS Pathogens·2025· 1 citedOpen Access
Fexinidazole and Corallopyronin A target <i>Wolbachia</i> -infected sheath cells present in filarial nematodes
2025Open Access
Differential susceptibility of Onchocerca ochengi adult male worms to flubendazole in gerbils and hamsters
Parasitology Research·2024
Repurposed Drugs That Activate Autophagy in Filarial Worms Act as Effective Macrofilaricides
Pharmaceutics·2024· 2 citedOpen Access
Combinations of the azaquinazoline anti-Wolbachia agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasis
Frontiers in Microbiology·2024· 6 citedOpen Access
Discovery of New Broad-Spectrum Anti-Infectives for Eukaryotic Pathogens Using Bioorganometallic Chemistry
Journal of Medicinal Chemistry·2023· 8 citedOpen Access
Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to Onchocerca volvulus in Mice and Non-Human Primates
Vaccines·2023· 5 citedOpen Access
Discovery of New Broad-Spectrum Anti-Infectives for Eukaryotic Pathogens Using Bioorganometallic Chemistry
2023· 1 citedOpen Access
Survival of worm masses of Onchocerca ochengi in gerbils and hamsters: implications for the development of an in vivo macrofilaricide screening model
Parasitology Research·2023· 3 cited
Development and validation of small animal models for onchocerciasis and loiasis microfilaricide discovery
PLoS neglected tropical diseases·2023· 3 citedOpen Access
Survival of adult female worms of Onchocerca change in gerbils and hamsters: implications for the development of an in vivo macrofilaricide screening model
Research Square (Research Square)·2022Open Access
Development of a Vaccine Against<i>Onchocerca volvulus</i>
2022
The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways
Frontiers in Immunology·2022· 2 citedOpen Access
Aspartyl Protease Inhibitors as Anti-Filarial Drugs
Pathogens·2022· 8 citedOpen Access
Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis
Vaccines·2022· 9 citedOpen Access
Localization and RNA Interference-Driven Inhibition of a Brugia malayi-Encoded Interleukin-5 Receptor Binding Protein
Infection and Immunity·2022Open Access
Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi
Frontiers in Cellular and Infection Microbiology·2022· 14 citedOpen Access
Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide Leads
Pharmaceuticals·2022· 7 citedOpen Access
Development of a recombinant vaccine against human onchocerciasis
Expert Review of Vaccines·2021· 17 cited
page 1 of 11Next →

Frequent Co-authors

Yelena Oksov(11), Elodie Ghedin(8), María Elena Bottazzi(7), Peter J. Hotez(7), David B. Guiliano(5), Thomas R. Unnasch(5), James McCarthy(5), Bin Zhan(5), Jing Liu(5), Sarwar Hashmi(5), Alexandra Grote(5), Shibo Jiang(5), David Abraham(5), Thomas B. Nutman(4), Roger K. Prichard(4), María‐Gloria Basáñez(4), Nancy Tricoche(4), Tellervo Huima(4), James H. McKerrow(4), Wilson Tawe(4)